Nasus Pharma Ltd (NSRX): Shares Outstanding

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2025-12-31 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

9.02M
As of 2025-12-31. As filed; likely tagged in the wrong unit
2024-12-31: 7.36M2025-12-31: 9.02M9.02M
2024-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-319.02Mn/a2026-03-25, Balance as of period end
2024-12-317.36Mn/a2026-03-25, Balance as of period end